AnaptysBio, Inc. (ANAB)
47.54
-0.19
(-0.40%)
USD |
NASDAQ |
Nov 04, 16:00
47.54
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Price : 47.54 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 47.36 | 48.35 | 47.36 | 47.73 | 304855.0 |
| Nov 02, 2026 | 48.33 | 48.37 | 46.90 | 46.91 | 281488.0 |
| Oct 30, 2026 | 48.68 | 48.97 | 47.88 | 48.28 | 293617.0 |
| Oct 29, 2026 | 50.85 | 51.22 | 48.33 | 48.64 | 414382.0 |
| Oct 28, 2026 | 49.59 | 50.55 | 49.00 | 50.50 | 309827.0 |
| Oct 27, 2026 | 49.24 | 50.02 | 48.70 | 49.63 | 349580.0 |
| Oct 26, 2026 | 48.97 | 49.62 | 47.98 | 48.77 | 417196.0 |
| Oct 23, 2026 | 48.19 | 48.88 | 47.05 | 48.73 | 468215.0 |
| Oct 22, 2026 | 47.65 | 48.51 | 46.83 | 48.10 | 254919.0 |
| Oct 21, 2026 | 45.48 | 48.48 | 45.48 | 47.94 | 664462.0 |
| Oct 20, 2026 | 49.57 | 51.86 | 44.02 | 45.43 | 1.206M |
| Oct 19, 2026 | 47.33 | 49.88 | 47.33 | 49.24 | 468355.0 |
| Oct 16, 2026 | 48.56 | 48.56 | 46.46 | 46.61 | 413644.0 |
| Oct 15, 2026 | 47.43 | 48.83 | 46.93 | 48.71 | 416304.0 |
| Oct 14, 2026 | 45.25 | 47.24 | 45.00 | 46.67 | 494172.0 |
| Oct 13, 2026 | 45.53 | 46.12 | 45.16 | 45.59 | 416538.0 |
| Oct 12, 2026 | 46.16 | 46.78 | 45.98 | 46.04 | 371657.0 |
| Oct 09, 2026 | 46.11 | 47.19 | 45.81 | 45.95 | 495669.0 |
| Oct 08, 2026 | 45.36 | 46.77 | 44.74 | 46.21 | 554155.0 |
| Oct 07, 2026 | 47.00 | 47.39 | 45.62 | 45.65 | 766532.0 |
| Oct 06, 2026 | 49.41 | 49.41 | 47.35 | 47.89 | 627091.0 |
| Oct 05, 2026 | 48.53 | 49.84 | 47.52 | 49.20 | 595547.0 |
| Oct 02, 2026 | 48.97 | 49.83 | 48.28 | 48.53 | 441125.0 |
| Oct 01, 2026 | 49.94 | 50.98 | 48.13 | 48.63 | 512335.0 |
| Sep 30, 2026 | 50.13 | 52.02 | 49.39 | 50.26 | 1.430M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.985 |
| Amgen, Inc. | 478.34 |
| Anika Therapeutics, Inc. | 20.37 |
| BioCryst Pharmaceuticals, Inc. | 8.26 |
| Imunon, Inc. | 0.9157 |
Price Related Metrics
| PE Ratio | 7.375 |
| PS Ratio | 5.941 |
| Price to Book Value | 133.52 |
| Price to Free Cash Flow | 78.13 |
| Earnings Yield | 13.56% |
| Market Cap | 1.413B |
| Operating PE Ratio | 10.54 |
| Normalized PE Ratio | 7.375 |